Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

PFE - Pfizer Inc.


Close
29.01
0.290   1.000%

Share volume: 37,110,584
Last Updated: Fri 30 Aug 2024 10:02:13 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) : 0.87%

PREVIOUS CLOSE
CHG
CHG%

$28.72
0.29
1.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
30%
Profitability 13%
Dept financing 25%
Liquidity 75%
Performance 37%
Company vs Stock growth
vs
Performance
5 Days
0.38%
1 Month
-7.58%
3 Months
4.32%
6 Months
10.44%
1 Year
-14.43%
2 Year
-30.30%
Key data
Stock price
$29.01
P/E Ratio 
-63.32
DAY RANGE
$28.67 - $29.05
EPS 
-$0.46
52 WEEK RANGE
$24.48 - $34.27
52 WEEK CHANGE
-$0.14
MARKET CAP 
164.388 B
YIELD 
5.63%
SHARES OUTSTANDING 
5.667 B
DIVIDEND
$0.42
EX-DIVIDEND DATE
07/26/2024
NEXT EARNINGS DATE
10/29/2024
BETA 
0.26
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$21,579,869
AVERAGE 30 VOLUME 
$27,329,186
Company detail
CEO:
Region: US
Website: https://www.pfizer.com/
Employees: 83,000
IPO year: -
Issue type: Common Stock
Market: NYSE
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services

Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. The company was established in 1849 in New York by two German entrepreneurs, Charles Pfizer and his cousin Charles F. Erhart.

Recent news